| Bioactivity | SARS-CoV-2-IN-86 (Compound 2734589) is a dual inhibitor of the methyltransferases nsp14 and nsp16 of SARS-CoV-2. SARS-CoV-2-IN-86 exhibits low toxicity with a LD50 of 700 mg/kg according to toxicity analysis predict[1]. | ||||||||||||
| CAS | 368866-07-3 | ||||||||||||
| Formula | C26H30N2O6 | ||||||||||||
| Molar Mass | 466.53 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Thomas J, et al., Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2. Sci Rep. 2024 Apr 29;14(1):9801. |
SARS-CoV-2-IN-86
CAS: 368866-07-3 F: C26H30N2O6 W: 466.53
SARS-CoV-2-IN-86 (Compound 2734589) is a dual inhibitor of the methyltransferases nsp14 and nsp16 of SARS-CoV-2. SARS-Co
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.